Sort by
Refine Your Search
-
The Cambridge Institute for Medical Research (CIMR) invites applications from postdoctoral researchers interested in sponsorship for career development fellowships that enable the establishment
-
research and development efforts. Through a competitive selection process, the program identifies exceptionally talented individuals at various career stages, from recent graduates to experienced researchers
-
lab has an outstanding track record in developing and applying cutting-edge genetic, genomic, and systems biology approaches to study neurodegenerative disorders including HD and Alzheimer’s disease (AD
-
-derived specimens. In addition, experimental therapeutics will be developed based on preliminary findings. These discoveries are expected to provide a strong foundation for future clinical translation and
-
Clinic, you will have access not only to pathology slide data, but the full spectrum of multimodal and longitudinal clinical data needed to develop personalized diagnostic or predictive AI tools. As a
-
the causes of paediatric brain cancers and develop new therapies. With the recent establishment of an mRNA vaccine trial to treat paediatric brain cancer by our laboratory and colleagues we continue to
-
autoantibodies in autoimmune disease pathology, to reveal the underlying mechanisms by which anti-MICL autoantibodies mediate their pathological effects and develop approaches to block the effect
-
-impact research aimed at understanding how neural circuits shape behaviour. The role offers substantial scope to influence experimental direction, develop innovative approaches, and contribute
-
to develop and carry out research at the intersection of oncology and health policy under shared mentorship between these programs. The goal of this program is to develop the next generation of leaders in
-
research, the FSTM seeks to generate and disseminate knowledge and train new generations of responsible citizens in order to better understand, explain and advance society and environment we live in